๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

2,4-DOPA: A Targeted Prodrug of Potential Use in the Treatment of Malignant Melanoma

โœ Scribed by MARK E. MORRISON; MARY JANE YAGI; GERALD COHEN

Book ID
118721330
Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
135 KB
Volume
435
Category
Article
ISSN
0890-6564

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The use of oral BCG in the treatment of
The use of oral BCG in the treatment of metastatic malignant melanoma
โœ Pritchard, Kathleen I. ;Cowan, Donald H. ;Baker, Michael A. ;Osoba, David ;Phill ๐Ÿ“‚ Article ๐Ÿ“… 1976 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 515 KB

## Abstract This study assesses the effects of oral BCG, as a single agent, on tumor progression and on cellโ€mediated immune function in patients with metastatic malignant melanoma. Thirty patients were studied including 22 with measurable metastatic lesions and 8 with no detectable disease, follow

Targeting cytotoxic T-lymphocyte antigen
Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4) : A novel strategy for the treatment of melanoma and other malignancies
โœ Steven J. O'Day; Omid Hamid; Walter J. Urba ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 511 KB

## Abstract Cancer immunotherapy centers on modulating the host's tumorโ€directed immune response. One promising approach involves augmentation of cellโ€mediated immunity by interrupting Tโ€cell pathways responsible for immune downโ€regulation or tolerance. The discovery of cytotoxic Tโ€lymphocyte antig